Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sytheon Obtains Isosorbide Patent - Happi
Company News, Patents

Sytheon Obtains Isosorbide Patent

Will enter the dermatological market for treating diseases caused by autoimmune imbalances.

According to Sytheon, there are certain novel esters of isosorbide that have been found to address defects or imbalances in keratinocyte differentiation, repair skin barrier building and defense, and improve overall stratum corneum development, structure and architecture. Specifically, Sytheon says that certain esters of isosorbide are capable of modifying, recalibrating and/or regulating the expression of genes, genetic networks and cellular pathways in mammalian skin for improving and/or repairing the epidermis and its function as well as in addressing, combating, mitigating and/or preventing the manifestation of disease conditions associated with certain diseases and defects or imbalances in the skin.
 
Having secured this patent, Sytheon says it is now committed to enter, through its sister company Symbionyx Phamaceuticals Inc., the dermatological market for treating diseases caused by autoimmune imbalances.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters